» Articles » PMID: 22205956

Modeling the Population-level Effects of Male Circumcision As an HIV-preventive Measure: a Gendered Perspective

Overview
Journal PLoS One
Date 2011 Dec 30
PMID 22205956
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence from biological, epidemiological, and controlled intervention studies has demonstrated that male circumcision (MC) protects males from HIV infection, and MC is now advocated as a public-health intervention against HIV. MC provides direct protection only to men, but is expected to provide indirect protection to women at risk of acquiring HIV from heterosexual transmission. How such indirect protection interacts with the possibility that MC campaigns will lead to behavior changes, however, is not yet well understood. Our objective here is to investigate the link between individual-level effects of MC campaigns and long-term population-level outcomes resulting from disease dynamics, looking at both genders separately, over a broad range of parameters.

Methods And Findings: We use simple mathematical models of heterosexual transmission to investigate the potential effects of a circumcision scale-up, combined with possible associated behavioral disinhibition. We examine patterns in expected long-term prevalence using a simple equilibrium model based on transmission factors, and validate our results with ODE-based simulations, focusing on the link between effects on females and those on males.We find that the long-term population-level effects on females and males are not strongly linked: there are many possible ways in which an intervention which reduces prevalence in males might nonetheless increase prevalence in females.

Conclusions: Since an intervention that reduces long-term male prevalence could nonetheless increase long-term female prevalence, MC campaigns should explicitly consider both the short-term and long-term effects of MC interventions on females. Our findings strongly underline the importance of pairing MC programs with education, support programs and HIV testing and counseling, together with other prevention measures.

Citing Articles

Association between medical male circumcision and HIV risk compensation among heterosexual men: a systematic review and meta-analysis.

Gao Y, Yuan T, Zhan Y, Qian H, Sun Y, Zheng W Lancet Glob Health. 2021; 9(7):e932-e941.

PMID: 33939956 PMC: 8690595. DOI: 10.1016/S2214-109X(21)00102-9.


Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized Sub-Saharan countries.

Shi C, Li M, Dushoff J PLoS One. 2017; 12(4):e0175928.

PMID: 28441458 PMC: 5404849. DOI: 10.1371/journal.pone.0175928.


Operations research in global health: a scoping review with a focus on the themes of health equity and impact.

Bradley B, Jung T, Tandon-Verma A, Khoury B, Chan T, Cheng Y Health Res Policy Syst. 2017; 15(1):32.

PMID: 28420381 PMC: 5395767. DOI: 10.1186/s12961-017-0187-7.


Towards a gender perspective in qualitative research on voluntary medical male circumcision in east and southern Africa.

Martinez Perez G, Duran L, Gasch A, Desmond N Glob Public Health. 2015; 10(5-6):626-38.

PMID: 25727455 PMC: 5207302. DOI: 10.1080/17441692.2015.1014826.


A new approach to measuring partnership concurrency and its association with HIV risk in couples.

Helleringer S, Mkandawire J, Kohler H AIDS Behav. 2014; 18(12):2291-301.

PMID: 24817498 PMC: 4496791. DOI: 10.1007/s10461-014-0788-x.


References
1.
Podder C, Sharomi O, Gumel A, Moses S . To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control. Bull Math Biol. 2007; 69(8):2447-66. DOI: 10.1007/s11538-007-9226-9. View

2.
Padian N, McCoy S, Abdool Karim S, Hasen N, Kim J, Bartos M . HIV prevention transformed: the new prevention research agenda. Lancet. 2011; 378(9787):269-78. PMC: 3606928. DOI: 10.1016/S0140-6736(11)60877-5. View

3.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

4.
Nagelkerke N, Moses S, de Vlas S, Bailey R . Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007; 7:16. PMC: 1832203. DOI: 10.1186/1471-2334-7-16. View

5.
Jackson D, Martin Jr H, Bwayo J, Nyange P, Rakwar J, Kashonga F . Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS. 1995; 9(11):1279-83. DOI: 10.1097/00002030-199511000-00010. View